Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Piperazine derivatives for lower urinary tract disorders designed at Recordati

March 23, 1999

Ono-4057: BLT receptor antagonist with beneficial effects in rat model of nephritis

March 22, 1999

TGF-beta inhibitors for nephritis disclosed by Tsumura

March 16, 1999

Zeria patents new series for BPH

March 15, 1999

Orally active, selective V2 agonists in development at AHP

March 12, 1999

Recordati claims potent and selective 5-HT1A receptor antagonists for urinary disorders

March 12, 1999

New Drug Submission for Ditropan accepted for review in Canada

March 10, 1999

Microbially produced 5alpha-reductase inhibitor discovered at Snow Brand

March 9, 1999

Licensing opportunity from VUFB: alpha2-adrenoceptor antagonist for BPH and heart failure

Feb. 16, 1999

PKC inhibitors designed at Otsuka

Feb. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...